Home › Trial NCT00940563
A Prospective, Multicenter Study on Best Clinical Use of Imatinib in the Advanced Gastrointestinal Stromal Tumors
- Trial IDNCT00940563
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorNovartis Pharmaceuticals
- Enrollment135
- Start date2002-03
- ConditionsAdvanced Gastrointestinal Stromal Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.